Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Second-generation H1-receptor antagonists.

F E Simons1, K J Simons

  • 1Department of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba.

Annals of Allergy
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of antihistamines in the new millennium.

Postgraduate medicine·2009
Same author

Genetic analysis of the species cytoplasm specific gene (scs d) derived from durum wheat.

The Journal of heredity·2005
Same author

Constant infusion of epinephrine, but not bolus treatment, improves haemodynamic recovery in anaphylactic shock in dogs.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2004
Same author

Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical?

The Journal of allergy and clinical immunology·2001
Same author

Socioeconomic status, drug insurance benefits, and new prescriptions for inhaled corticosteroids in schoolchildren with asthma.

Archives of pediatrics & adolescent medicine·2001
Same author

Expression, purification, characterization and clinical relevance of rAed a 1--a 68-kDa recombinant mosquito Aedes aegypti salivary allergen.

International immunology·2001
Same journal

Hay fever; a review of the literature for 1945.

Annals of allergy·2010
Same journal

Nasal and sputum smears.

Annals of allergy·2010
Same journal

Determination of penicillin-susceptible strains of bacteria.

Annals of allergy·2010
Same journal

Fleabite reactions; clinical and experimental observations and effect of histamine-azoprotein therapy.

Annals of allergy·2010
Same journal

D.H.E. 45 (dihydroergotamine) in the treatment of allergic megraine.

Annals of allergy·2010
Same journal

Antigenicity of proteins in relation to allergy.

Annals of allergy·2010
See all related articles

Second-generation H1-receptor antagonists offer improved safety and efficacy over older drugs, with minimal sedation. Understanding their distinct properties is key for effective clinical use in allergic conditions.

Area of Science:

  • Pharmacology
  • Allergy and Immunology

Background:

  • First-generation H1-receptor antagonists readily cross the blood-brain barrier, leading to central nervous system side effects like sedation.
  • Second-generation H1-receptor antagonists exhibit reduced central nervous system penetration and preferentially target peripheral H1-receptors.

Purpose of the Study:

  • To compare the pharmacological and clinical profiles of second-generation H1-receptor antagonists with their first-generation counterparts.
  • To elucidate the differences in pharmacokinetics and pharmacodynamics to guide optimal clinical application.

Main Methods:

  • Review of existing pharmacological data and clinical trial outcomes for both generations of H1-receptor antagonists.
  • Comparative analysis of receptor binding affinity, CNS penetration, and side effect profiles.

Related Experiment Videos

Main Results:

  • Second-generation H1-receptor antagonists demonstrate significantly less sedation compared to placebo and first-generation agents.
  • These newer agents are increasingly utilized for allergic rhinoconjunctivitis and urticaria-associated pruritus.
  • A mild benefit is observed in chronic asthma management, but they have not replaced older drugs for atopic dermatitis or anaphylaxis.

Conclusions:

  • Second-generation H1-receptor antagonists represent a significant advancement in managing allergic conditions due to their improved safety and targeted action.
  • Clinical differentiation based on pharmacology and pharmacodynamics is crucial for maximizing therapeutic benefits and patient outcomes.